Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aricept in severe Alzheimer's disease
NCT00096473Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2001
- Primary completion
- Jun 2005
- Countries
- 6
01
Overview
A Phase 3 trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Started Jan 2001; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00096473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096473.